NEWS

Recent News

POC FOR CYTOKINES

7:02 pm MST |  Jun 8, 2018  |  BioCentury  |  Product DevelopmentPOC FOR CYTOKINESCytokines are emerging as a logical combination partner to boost PD-1 responsesby Emily Cukier, Senior...

read more

NantKwest to Present at Upcoming Investment Conferences

CULVER CITY, CA, May 16, 2018 - NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting and conducting one-on-meetings at several investment conferences during the month of...

read more

Archives

Media Contact:

Jen Hodson
NantKwest
Telephone: 562-397-3639
Email: Press@NantKwest.com

CONTACT NANTKWEST
CLICK HERE

NK-92 ®️ CELLS FOR ASSAYS
CLICK HERE